Titanium plates as bacterial adhesion substrates for scanning electron microscopy.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J E Uzodinma.
Explore the source record for details and available documents.
Chlordecone was reported to produce neurotoxicity by modulating the Na+ pump in adult rat brain. The present in vitro and in vivo studies were initiated to investigate its effect on maturing rat brain ATPases. Neonates were exposed to chlordecone for 20 d indirectly through lactation by treating the mothers po and from 21 to 50 d as adults. Brain P2 fractions were prepared from treated and control rats. Na+,K+, oligomycin-sensitive (O.S.) and oligomycin-insensitive (O.I.) Mg2+-ATPase activities were increased with age up to d 20. Na+,K+- and O.S. Mg2+-ATPases were inhibited in both in vitro and in vivo treatment with chlordecone. Both these enzymes were more sensitive to chlordecone in the neonatal brains as compared to adult rats (20-50 d). The activity of Mg2+-ATPase but not of Na+,K+-ATPase was restored to normal activity after 20 d of withdrawal of chlordecone treatment. O.I. Mg2+-ATPase was insensitive to chlordecone treatment in all age groups. Ca2+-ATPase activity was not increased with age; however, it was more sensitive to chlordecone in neonates as compared to adults. These results suggest that the Na+ pump, Ca2+-ATPase, and ATP synthesizing enzymes are highly sensitive to chlordecone during early postnatal development.
Explore the source record for details and available documents.
In vitro effects of toxaphene on Ca2+-ATPase activity and 45Ca2+-uptake were studied in mitochondrial fractions of heart, kidney and liver tissues of rat. Mitochondrial fractions were prepared by the conventional centrifugation method. Ca2+-ATPase activity was determined by measuring the inorganic phosphate liberated during ATP hydrolysis. Toxaphene inhibited Ca2+-ATPase in a concentration dependent manner in all the three tissues. Substrate activation kinetics, with heart, kidney and liver tissue fractions, revealed that toxaphene inhibited Ca2+-ATPase activity non-competitively by decreasing the maximum velocity of the enzyme without affecting the enzyme-substrate affinity. Toxaphene also inhibited mitochondrial 45Ca2+-uptake in the three selected tissues in a concentration dependent manner. These results indicate that toxaphene is an inhibitor of mitochondrial Ca2+-ATPase and calcium transport in heart, kidney and liver tissues of rat.
Effect of tricyclohexylhydroxytin (plictran) on Ca2+-ATPase activity was studied in rat brain synaptosomes under in vitro and in vivo conditions. Plictran inhibited basal Ca2+-ATPase activity with an IC50 value of 6 nM suggesting its interaction with calcium transport phenomenon. Plictran inhibited calmodulin (CaM) activated Ca2+-ATPase in a concentration-dependent manner. A complete reversal of calmodulin activation of Ca2+-ATPase was observed with 2-3 nM plictran. A 50 per cent decrease of CaM activated Ca2+-ATPase was observed with 0.5 nM plictran, a concentration at which no significant effect was observed on basal enzyme activity. Of all the brain fractions studied, calmodulin levels in P2 fractions alone were reduced significantly to about 75 per cent of control values in plictran treated rats. The synaptosomal Ca2+-ATPase was also decreased by 35 per cent, 42 per cent and 65 per cent in 10, 20 and 40 mg plictran kg-1 day-1 treated rats for 3 days respectively. The activity levels of Ca2+-ATPase in 10 and 20 mg plictran kg-1 day-1 treated rats were restored to normal level by exogenously added calmodulin. These results suggest that plictran may disrupt synaptic function by altering calcium and calmodulin regulated processes in the central nervous system.